title: Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter.
abstract: The cryoballoon catheter ablates atrial fibrillation (AF) triggers in the left atrium (LA) and pulmonary veins (PVs) via transseptal access. The typical transseptal puncture site is the fossa ovalis (FO) - the atrial septum's thinnest section. A potentially beneficial transseptal site, for the cryoballoon, is near the inferior limbus (IL). This study examines an alternative transseptal site near the IL, which may decrease the frequency of acute iatrogenic atrial septal defect (IASD). Also, the study evaluates the acute pulmonary vein isolation (PVI) success rate utilizing the IL location. 200 patients were evaluated by retrospective chart review for acute PVI success rate with an IL transseptal site. An additional 128 IL transseptal patients were compared to 45 FO transseptal patients by performing Doppler intracardiac echocardiography (ICE) post-ablation to assess transseptal flow after removal of the transseptal sheath. After sheath removal and by Doppler ICE imaging, 42 of 128 (33%) IL transseptal patients demonstrated acute transseptal flow, while 45 of 45 (100%) FO transseptal puncture patients had acute transseptal flow. The difference in acute transseptal flow detection between FO and IL sites was statistically significant (P <0.0001). Furthermore, 186 of 200 patients (with an IL transseptal puncture) did not need additional ablation(s) and had achieved an acute PVI by a "cryoballoon only" technique. An IL transseptal puncture site for cryoballoon AF ablations is an effective location to mediate PVI at all four PVs. Additionally, an IL transseptal location can lower the incidence of acute transseptal flow by Doppler ICE when compared to the FO. Potentially, the IL transseptal site may reduce later IASD complications post-cryoballoon procedures.
authors.affiliation: Department of Cardiovascular Medicine, Cavanagh Heart Center, Banner-University Medical Center.
authors.forename: Michael E
authors.initials: ME
authors.lastname: Rich
authors.affiliation: Mayo Medical School, Mayo Clinic.
authors.forename: Andrew
authors.initials: A
authors.lastname: Tseng
authors.affiliation: AF Solutions, Medtronic plc.
authors.forename: Hae W
authors.initials: HW
authors.lastname: Lim
authors.affiliation: Cardiology Division, Stanford University School of Medicine, Stanford University.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Wang
authors.affiliation: Department of Cardiovascular Medicine, Cavanagh Heart Center, Banner-University Medical Center; wilwsu@gmail.com.
authors.forename: Wilber W
authors.initials: WW
authors.lastname: Su
mesh_terms: D001281:Atrial Fibrillation / Q000601:surgery*; D006328:Cardiac Catheterization / Q000295:instrumentation / Q000379:methods*; D017115:Catheter Ablation / Q000295:instrumentation / Q000379:methods*; D003452:Cryosurgery / Q000295:instrumentation / Q000379:methods*; D006344:Heart Septal Defects, Atrial / Q000517:prevention & control*; D006346:Heart Septum / Q000601:surgery*; D006801:Humans; D012189:Retrospective Studies